Companies / T3D

333D LIMITED

ASX:T3DCommercial & Professional Services
211.4M shares on issueASX (delayed) · as of 28 July 2026$0.034price · delayed$6.8Mmarket cap · indicative
B
Dilution grade

Share count grew 20% in 24 months; runway 4–8 quarters; 1 cash raise in 24 months

Cash runway6.4 quarters of funding
Share-count growth (24m)20.0%
Raise cadence (24m)1 cash raise
Options & rights overhang3.1% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

333D LIMITED's ordinary share count rose 20.0% between November 2024 and March 2026, to 211M shares. The company raised capital once in that period for total proceeds of A$1.0M, with the most recent raise dated September 2025 for A$1.0M. Options and rights on issue could convert into 7M new shares, equal to 3.1% of the current share count, and 0% are in the money at the current share price. At the March 2026 quarter the company reported A$903K in available cash, equivalent to about 6.4 quarters of funding at its recent spending rate. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
3.1%
Max option dilution
0.0%
ITM option dilution
1
Raises · last 12 months
6.4 qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 211.4M per ASX (delayed) (28 July 2026).
183.6M193.8M204.0MDec 24Sept 25July 26Cash raise · 11 Sept 2025

Cash runway

—
Cover not computed for the latest quarter.
$903k available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
13 Mar 20262A · quoted issueT3D : ORDINARY FULLY PAID211.4MAppendix 2A
9 Dec 20253G · unquotedORDINARY FULLY PAID201.5MAppendix 3G
20 Oct 20252A · quoted issueT3D : ORDINARY FULLY PAID201.5MAppendix 2A
25 Sept 20252A · quoted issueT3D : ORDINARY FULLY PAID198.9MAppendix 2A
15 July 20252A · quoted issueT3D : ORDINARY FULLY PAID188.9MAppendix 2A
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

1 cash raise in the last 24 months · 1 in the last 12 months

$1.0M
Capital raise
11 Sept 2025
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

3.1%
Total overhang · of current shares
0.0%
In the money · at current price
6.5M
Potential new shares
—
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
9 Dec 2025Dr Nigel FinchOther———3Y notice
9 Dec 2025Dr Richard PettyOther———3Y notice
9 Dec 2025Mr John ConidiOther———3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

8 June 2026Investment in Firmus and Update on AI Product Development
22 Apr 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
13 Mar 2026Application for quotation of securities - T3D
24 Feb 2026$PHalf Yearly Report and Accounts
1 Feb 2026$PUpdate on Bitcoin Treasury Management
30 Jan 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
9 Dec 2025Replacement Change of Director's Interest Notice
9 Dec 2025Change of Director's Interest Notice x 3
9 Dec 2025Notification regarding unquoted securities - T3D
28 Nov 2025Results of 2025 Annual General Meeting
29 Oct 2025Notice of Annual General Meeting/Proxy Form
20 Oct 2025Change of Director's Interest Notice x 3
20 Oct 2025Application for quotation of securities - T3D
19 Oct 2025Update - Proposed issue of securities - T3D
19 Oct 2025AGM Date, Vesting of Rights, Extension of Cleansing Offer
15 Oct 2025Ceasing to be a substantial holder - T3D
13 Oct 2025$PQuarterly Activities/Appendix 4C Cash Flow Report
12 Oct 2025Proposed issue of securities - T3D
12 Oct 2025Cleansing Prospectus
5 Oct 2025Full Body MRI Collaboration Agreement with BioScan 360

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.